With institutional knowledge of over 20 years, we have been instrumental in bringing platform technologies to deliver exploratory and complex chemistries, using parallel and conventional techniques. A dedicated kilo laboratory and analytical infrastructure with advanced equipment, facilitate the rapid supply of compounds. Our team of 1,200+ talented scientists provide novel, value engineered and environmentally friendly solutions.
Accelerating Drug Discovery with High-Throughput Parallel Chemistry
Parallel medicinal chemistry revolutionizes discovery by enabling simultaneous synthesis of large, diverse compound libraries. This high-throughput approach shortens timelines, enhances chemical diversity, and increases the likelihood of identifying potent, selective candidates faster.
At Aragen, we empower pharmaceutical, agrochemical, animal health, and biotech innovators through comprehensive parallel medicinal chemistry solutions. Our advanced library synthesis capabilities enable rapid exploration of chemical space, accelerating drug discovery and lead compound identification. We leverage cutting-edge technology and expert scientific know-how to propel your discovery projects with speed and precision.
Comprehensive Library Synthesis Solutions
End-to-End Library Synthesis Solutions
Scientific Excellence
State-of-the-Art Infrastructure
Why Aragen for Library Synthesis?
Partner with Aragen to accelerate your discovery pipeline. Our high-throughput library synthesis solutions combine advanced chemistry, automation, and expert project management to help you go from concept to candidate—faster, smarter, and more efficiently.
We screen transition metal mediated transformations using preplated catalyst/customized kits in glove boxes.
We have extensive expertise in asymmetric synthesis and chiral induction methods, enabling highly enantioselective or enantiospecific transformations to deliver compounds for the development of novel biomedical therapeutic agents.
Pioneering Sustainable, Scalable, and Cutting-Edge Electrochemistry Solutions
At Aragen, our electrochemistry platform leads innovation by delivering cleaner, safer, and more efficient synthetic routes tailored to drug discovery and agrochemical development. Leveraging advanced electrochemical methods, we unlock novel reactivity, enhance process sustainability, and accelerate timelines—from early discovery to kilogram-scale manufacturing.
Comprehensive Electrode Range for Versatile Transformations
Our expert team employs a broad selection of electrode materials—including platinum (Pt), magnesium (Mg), nickel (Ni), copper (Cu), reticulated vitreous carbon (RVC), and zinc (Zn)—to customize electrochemical conditions for diverse synthetic challenges. This flexibility enables efficient oxidative and reductive transformations across multiple chemical classes.
Efficient Cross-Coupling and Scalable Synthesis
Using state-of-the-art equipment such as ElectraSyn 2.0, we perform cross-coupling reactions at scales from 50 mg to 1 g, consistently achieving yields of 40–60%. This accelerates route optimization and reduces reaction times. Additionally, our VersaStat 3.0 platform supports seamless scale-up to kilogram quantities for reproducible, scalable manufacturing.
Proven Success in Real-World Applications
We excel at adapting literature-reported electrochemical reactions to practical medicinal and agrochemical projects, including challenging transformations beyond traditional methods such as:
These capabilities provide new avenues for molecular innovation and competitive project advantages.
Notable Electrochemical Transformations at Aragen
Environmentally Responsible Chemistry
Our electrochemical synthesis minimizes the use of toxic reagents, aligning with green chemistry principles. By enabling precise electrochemical control, we reduce environmental impact and enhance process safety.
Why Aragen for Electrochemical Synthesis?
Choosing Aragen means access to a world-class electrochemistry platform combining innovative technology with deep synthetic expertise. Our scalable, green electrochemical methods accelerate discovery and development, reduce hazardous reagent risks, and unlock previously inaccessible synthetic possibilities. Leverage our proven capabilities to streamline your synthetic pathways, enhance molecular complexity, and meet project milestones faster.
Unlocking Novel Synthetic Pathways with Light-Driven Catalysis
At Aragen, we harness photo-redox catalysis to transform organic synthesis and accelerate drug discovery and development. Integrating cutting-edge photo-redox technologies, we design and execute innovative synthetic methodologies that unlock previously inaccessible transformations—bringing complex molecular targets to life efficiently and precisely.
Driving Efficiency Through Advanced Photo-Redox Catalysis
Our expertise spans microscale catalyst screening to large-scale production using state-of-the-art technologies. We utilize catalysts based on ruthenium (Ru), iridium (Ir), nickel (Ni), and palladium (Pd), conducting rapid microscale screenings to optimize conditions for your synthetic needs. For scale-up, dedicated photo-flow reactors enable smooth transitions from milligram to kilogram scales, ensuring robust and reproducible outcomes.
Comprehensive Photochemistry Capabilities at Aragen
Versatility Across Broad Chemical Space
Our photoredox platform efficiently couples diverse substrates such as carboxylic acids, esters, halides, alcohols, amines, and boryls. Key transformations routinely delivered include:
Why Aragen for Photoredox Catalysis?
Partner with Aragen to benefit from a synergy of expertise and technology in photoredox chemistry. We transform synthetic challenges into scalable, efficient, and innovative solutions—delivering projects faster with greater molecular complexity to fuel your pipeline’s success.
Dedicated Fee-for-Service (FFS) Solutions for Accelerated Drug Discovery
At Aragen, we understand that innovation in drug discovery demands agility, precision, and deep scientific expertise. Our Dedicated Fee-for-Service (FFS) model is designed to provide flexible, scalable, and high-quality solutions tailored to your research needs. By partnering with us, you gain access to a comprehensive suite of capabilities across multiple therapeutic modalities and chemistry platforms.
Our Specialty Services
Design & Synthesis
Why Choose Our Dedicated FFS Model?
Partner with us to transform your ideas into impactful therapies.
Contact us today to learn how our dedicated FFS services can empower your drug development journey.
Driving Innovation with Rapid Scale-Up FFS Capability at Aragen
In today’s fast-paced drug development landscape, flexibility and speed are critical. Our dedicated Fee-for-Service (FFS) model empowers partners to accelerate discovery and development with specialized expertise across multiple modalities:
At Aragen, we are committed to accelerating your molecule’s journey from concept to commercialization with state-of-the-art infrastructure and expertise in rapid scale-up capabilities. Our integrated approach ensures seamless transition from R&D to manufacturing, backed by advanced technology and robust process safety systems.
R&D Excellence
Robust Reactor Area
Process Safety at the Core
Safety is non-negotiable. Our advanced tools for process safety assessment include:
Cost effective and quick procurement.
Our SCM team are very much efficient to procure KSMs from local and external supplier to achieve cost effective with quick TAT.
With these capabilities, Aragen empowers clients with speed, scalability, and safety, ensuring successful delivery of projects from grams to multi-kilogram scale.
Let’s collaborate to bring your ideas to life—faster, smarter, and safer.
